Skip to Main Content

Paper Details

Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography.
Eur Urol Oncol
0
2023
High-risk Prostate Cancer, PATIENT, PCa, PSMA, Prostate-specific Membrane Antigen, Prostate-specific membrane antigen, extraprostatic disease, extraprostatic prostate cancer, localized PCa, men, patients, prostate cancer, prostate-specific membrane antigen
Gallium Radioisotopes, Humans, Male, Positron Emission Tomography Computed Tomography, Positron-Emission Tomography, Prostate, Prostatic Neoplasms, Transcriptome
Author NameAffiliation
Clayton P SmithUniversity of California-Los Angeles
James A Proudfoot
Paul C BoutrosUniversity of California-Los Angeles
Robert E ReiterUniversity of California-Los Angeles
Luca F ValleUniversity of California-Los Angeles
Matthew B RettigUniversity of California-Los Angeles
Nicholas G NickolsUniversity of California-Los Angeles
Felix Y FengUniversity of California-San Francisco
Paul L NguyenBrigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School
Himanshu Nagar
Daniel E SprattUniversity Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine
Gerhardt AttardUniversity College London Cancer Institute
Adam B WeinerUniversity of California-Los Angeles
Joanne B WeidhaasUniversity of California-Los Angeles
Jeremie CalaisDavid Geffen School of Medicine, University of California-Los Angeles
Ting Martin MaUniversity of California-Los Angeles
Elai Davicioni
Michael XiangUniversity of California-Los Angeles
Amar U KishanUniversity of California-Los Angeles
  • 1 - 19

Datasets

Release 1.2